Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Burgos – page 7

88 clinical trials in Burgos, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Burgos at a glance
88
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

88 trials in Burgos

Open in trial search

Mantle cell lymphoma

Not recruiting

Study on the Effectiveness and Safety of Ibrutinib and Rituximab for Patients with Indolent Mantle Cell Lymphoma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:Fundacion Geltamo

Pseudomonas infection

Not recruiting

Study on the Effectiveness and Safety of 7 vs. 14 Days of Antibiotic Treatment with Meropenem for Patients with Pseudomonas Aeruginosa Blood Infection

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin
  • Sponsor:Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla

Study Comparing Romiplostim and Dexamethasone with Dexamethasone Alone for Patients with Newly Diagnosed Primary Immune Thrombocytopenia

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Romiplostim
  • Sponsor:Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla

Breast cancer+1

Not recruiting

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Novartis Pharma AG

Study on Trastuzumab and Pertuzumab for Patients with HER2-Positive Breast Cancer Using a Response-Adapted Strategy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Medica Scientia Innovation Research S.L.

Huntington's disease

Not recruiting

Study on Long-Term Safety and Effects of PTC518 for Patients with Huntington's Disease

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Votoplam
  • Sponsor:Novartis Pharma AG

Study of Atezolizumab, Bevacizumab, and Tiragolumab for Patients with Untreated Advanced or Metastatic Liver Cancer

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG

Study Comparing Trelegy with LABA-LAMA Drug Combination for Improving COPD Control in High-Risk Patients

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Aclidinium Bromide
  • Sponsor:Fundacio Privada Mon Clinic Barcelona

Follicular lymphoma+1

Not recruiting

Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Incyte Corp.

Procedural pain

Not recruiting

Study on Improving Pain Relief After Surgery Using Tramadol and Dexketoprofen Based on Genetic Testing for Patients with Acute Postoperative Pain

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Metamizole Magnesium
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa

Fungal infection

Not recruiting

Study on Rezafungin Acetate for Children with Fungal Infections Aged Birth to Under 18 Years

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Rezafungin Acetate
  • Sponsor:Mundipharma Research Limited

Study of Obexelimab for Patients with Warm Autoimmune Hemolytic Anemia

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Obexelimab
  • Sponsor:Zenas Biopharma (USA) LLC

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Burgos

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials investigating treatments for various cancers, including hepatocellular carcinoma, breast cancer, and neuroendocrine tumors. Studies focus on evaluating novel therapeutic combinations and targeted treatments.

  • HER2-positive breast cancer therapies
  • Advanced liver cancer treatments
  • Colon cancer interventions

Several trials are exploring immunotherapy combinations and precision medicine approaches for better patient outcomes.

02 Hematological Disorders

Research focusing on blood disorders including immune thrombocytopenia, acute myeloid leukemia, and mantle cell lymphoma. Studies evaluate both novel therapies and treatment combinations.

  • ITP treatment innovations
  • Leukemia interventions
  • Lymphoma therapies

Trials aim to improve treatment responses and patient outcomes in various blood disorders.

03 Neurological Conditions

Clinical research examining treatments for Huntington's Disease and Parkinson's Disease, with a focus on cognitive improvements and disease modification strategies.

  • Cognitive function studies
  • Disease-modifying therapies
  • Long-term treatment effects

Investigations include both novel compounds and repurposed medications for neurodegenerative conditions.

04 Respiratory Medicine

Studies examining treatments for respiratory syncytial virus and chronic obstructive pulmonary disease, including vaccine development and therapeutic interventions.

  • RSV vaccine trials
  • COPD management
  • Pulmonary embolism treatment

Research focuses on both preventive strategies and treatment optimization.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.